HOME > Investor Relations > Financial Information > Financial Highlights

Financial Information

Financial Highlights


(Unit : Thousands of yen)

Accounting Term 16th 17th 18th 19th
Fiscal Period FY2014/3
As of March 31, 2014
(Consolidated)
FY2015/3
As of March 31, 2015
(Consolidated)
FY2016/3
As of March 31, 2016
(Consolidated)
FY2017/3
As of March 31, 2017
(Consolidated)
Net sales 1,617,572 1,958,554 2,290,287 2,302,908
Genomics Business 385,702 296,738 395,050 420,148
CRO Business 670,133 799,183 1,099,367 1,150,505
Advanced Medical Business 312,995 482,062 391,779 356,587
Pathological Diagnostics Business 251,711 396,779 413,778 399,294
Operating income △ 85,022 23,693 50,413 153,948
Net income △ 113,642 17,824 14,587 80,694
 
Total assets 3,563,800 3,573,785 3,905,445 3,902,426
Net assets 2,764,943 2,777,287 3,069,782 3,173,327
Shareholders' equity 2,700,072 2,764,739 3,042,942 3,194,745
Shareholders' equity to total assets (%) 75.8 77.4 78.2 81.0
 
ROE: Return on equity (%) △ 4.2 0.6 0.5 2.5
EPS: Net income per share (JPY) △ 8.39 1.29 1.05 5.63
BPS: Book-value per share (JPY) 198.21 198.81 214.27 220.20
PBR: Price bookvalue ratio 2.1 2.0 3.7 2.8
 
Shares outstanding (Share) 13,624,100 13,908,641 14,246,941 14,246,941
Market capitalization 5,613,129 5,577,365 11,426,046 8,957,483
 
Cash flows from operating activities △ 141,502 101,241 214,367 232,813
Cash flows from investing activities △ 174,871 △ 46,550 △ 664,721 △ 200,101
Cash flows from financing activities 371,304 △ 92,697 157,921 △ 27,298
Cash and cash equivalents at end of year 1,384,192 1,346,185 1,053,753 1,059,180
 
Number of employees (persons) 132 132 141 137

Financial Information

Financial Highlights
Financial Highlights

Information on consolidated business performance and financial position.

Consolidated Balance Sheets
Consolidated Balance Sheets

Consolidated balance sheets.

Consolidated of Statements Income
Consolidated of Statements Income

Consolidated statements of income.

Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows

Consolidated statements of cash flows.

  • Press Releases
Contact Us/Products&ServicesE-mail
  • Reproductive Technology Training
Back to Top